Multiple studies have revealed altered expression or mutation of many components (e.g. PIK3CA, PTEN, AKT) of the PI3K/AKT pathway in a broad range of human cancers [1]–[3], [10]–[12]. The gene discussed is PIK3CA; the disease is cancer.